NYC TCTTAC

Resources & Tools


FDA Modifications to Labeling Nicotine Replacement Therapy Products


FDA Revised Drug Safety Communication on Chantix & Zyban


Letter from OMH and DOHMH describing unrestricted Medicaid coverage for treating tobacco use